The South Korea Nuclear Imaging Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of COVID-19 (Corona Virus) on the product industry chain based on the upstream and downstream markets, on various regions and major countries and on the future development of the industry are pointed out.
The South Korean nuclear imaging market is expected to project a growth of 6.68% . The increasing prevalence of cancer, along with certain cardiovascular diseases, is the major driver for the South Korean nuclear imaging market. According to the Cancer Research and Treatment Organization, Korea, a total of 221,347 new cancer cases are estimated to be recorded in 2019, and males (120,352) are more likely to be affected than females (100,995). Additionally, increasing technological advancements in PET or SPECT imaging, simultaneously, with radionuclide/radiopharmaceutical therapy, are expected to propel the growth of the nuclear imaging market in South Korea.
Click the link to get a Sample Copy of the Report:
The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the South Korea Nuclear Imaging Market: DuChemBIO Co. Ltd, FutureChem, GE Healthcare, IBA Radiopharma Solutions, KAERI (Korea Atomic Energy Research Institute), KIRAMS (Korea Institute of Radiological & Medical Sciences), NuCare Inc., Samyoung Unitech, and Siemens Healthineers.
Key Market Trends
Cardiology Dominates the SPECT Application Segment in the South Korea Nuclear Imaging Market
The cardiology segment of the market studied is expected to show a faster growth in the South Korea Nuclear Imaging Market. A SPECT scan of the heart refers to a non-invasive nuclear imaging test that uses radioactive tracers. These tracers are injected into the blood, in order to produce pictures of the heart. SPECT is used to diagnose coronary artery disease, as well as to detect a heart attack. SPECT can demonstrate how well the heart is working and how well the blood is flowing to the heart. Cardiac SPECT is mostly safe for people. The amount of radiation is small, and one’s body is likely to get rid of it through kidneys, within about 24 to 72 hours. According to the WHO’s most recent findings (taken from 2015 figures), an average of 74.6 CVD-related fatalities were observed in South Korea, for every 100,000 people, in a year. According to the 2018 article, Current Status of Nuclear Cardiology in South Korea, in 2016, SPECT MPI (Myocardial Perfusion Imaging) had 12.8% share in the total gamma imaging studies. The recent installation of cadmium-zinc-telluride (CZT) cardiac-dedicated SPECT system in South Korea has brought even higher volumetric expansion of SPECT MPI. CZT SPECT-measured myocardial blood flow (MBF) and myocardial flow reserve (MFR) are also available in the country. Hence, the promising results and clinical usefulness of CZT SPECT MPI may undoubtedly promote nuclear cardiology in South Korea.
Influence Of The South Korea Nuclear Imaging Market Report:
-Comprehensive assessment of all opportunities and risk in the South Korea Nuclear Imaging market.
– South Korea Nuclear Imaging market recent innovations and major events.
-A detailed study of business strategies for growth of the South Korea Nuclear Imaging market-leading players.
-Conclusive study about the growth plot of South Korea Nuclear Imaging market for forthcoming years.
-In-depth understanding of South Korea Nuclear Imaging market-particular drivers, constraints and major micro markets.
-Favourable impression inside vital technological and market latest trends striking the South Korea Nuclear Imaging market.
The report has 150 tables and figures browse the report description and TOC:
What Are The Market Factors That Are Explained In The Report?
Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on regional scale.
Analytical Tools: The South Korea Nuclear Imaging Market Report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, SWOT analysis, feasibility study, and investment return analysis have been used to analyze the growth of the key players operating in the market.
Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.
Customization of the Report: This report can be customized as per your needs for additional data up to 3 companies or countries or 40 analyst hours.
Please connect with our sales team (firstname.lastname@example.org).
MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides Global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
email@example.com | firstname.lastname@example.org